Schwedhelm Edzard, Bartling Asja, Lenzen Henrike, Tsikas Dimitrios, Maas Renke, Brümmer Jens, Gutzki Frank-Mathias, Berger Jürgen, Frölich Jürgen C, Böger Rainer H
Clinical Pharmacology Unit, Institute of Experimental and Clinical Pharmacology, University Hospital Hamburg-Eppendorf, Germany.
Circulation. 2004 Feb 24;109(7):843-8. doi: 10.1161/01.CIR.0000116761.93647.30. Epub 2004 Feb 2.
Oxidative stress is involved in the pathophysiology of atherosclerosis, diabetes mellitus, hypertension, obesity, and cigarette smoking, all of these being risk factors for coronary heart disease (CHD). We tested the hypothesis that risk factors of CHD are associated with abundant systemic oxidative stress.
We conducted a case-control study with 93 CHD patients and 93 control subjects frequency-matched by age and sex. Urinary excretion of the F2-isoprostane 8-iso-prostaglandin (PG) F2alpha and its major urinary metabolite, 2,3-dinor-5,6-dihydro-8-iso-PGF2alpha, were measured by gas chromatography-tandem mass spectrometry. Body mass index, systolic blood pressure, and C-reactive protein were elevated in CHD patients (P<0.01). Urinary 8-iso-PGF2alpha and 2,3-dinor-5,6-dihydro-8-iso-PGF2alpha also differed, from 77 (interquartile range, 61-101) to 139 (93-231) pmol/mmol creatinine and from 120 (91-151) to 193 (140-275) pmol/mmol in control subjects and case subjects, respectively (P<0.001). 8-iso-PGF2alpha and its metabolite were highly correlated (Spearman's rho=0.664, P<0.001). HDL cholesterol was diminished in CHD patients (P<0.001). All of these characteristics predicted CHD in univariate analysis. In a multivariate model, the odds ratios were increased only for 8-iso-PGF2alpha (> or =131 pmol/mmol, P<0.001) and C-reactive protein (>3 mg/L, P<0.01), ie, by 30.8 (95% CI, 7.7-124) and 7.2 (1.9-27.6), respectively. 8-iso-PGF2alpha was found to be a novel marker in addition to known risk factors of CHD, ie, diabetes mellitus, hypercholesterolemia, hypertension, and smoking. Urinary excretion of 8-iso-PGF2alpha correlated with the number of risk factors for all subjects (P<0.001 for trend).
8-iso-PGF2alpha is a sensitive and independent risk marker of CHD.
氧化应激参与动脉粥样硬化、糖尿病、高血压、肥胖和吸烟的病理生理过程,所有这些都是冠心病(CHD)的危险因素。我们检验了冠心病危险因素与全身性氧化应激增加有关的假设。
我们进行了一项病例对照研究,纳入93例冠心病患者和93例年龄及性别频率匹配的对照者。采用气相色谱 - 串联质谱法测定尿中F2 - 异前列腺素8 - 异前列腺素(PG)F2α及其主要尿代谢产物2,3 - 二去甲 - 5,6 - 二氢 - 8 - 异 - PGF2α的排泄量。冠心病患者的体重指数、收缩压和C反应蛋白升高(P<0.01)。尿8 - 异 - PGF2α和2,3 - 二去甲 - 5,6 - 二氢 - 8 - 异 - PGF2α也存在差异,对照组分别为77(四分位间距,61 - 101)至139(93 - 231)pmol/mmol肌酐,病例组分别为120(91 - 151)至193(140 - 275)pmol/mmol(P<0.001)。8 - 异 - PGF2α及其代谢产物高度相关(Spearman秩相关系数rho = 0.664,P<0.001)。冠心病患者的高密度脂蛋白胆固醇降低(P<0.001)。所有这些特征在单因素分析中均能预测冠心病。在多因素模型中,仅8 - 异 - PGF2α(≥131 pmol/mmol,P<0.001)和C反应蛋白(>3 mg/L,P<0.01)的优势比增加,分别增加30.8(95%CI,7.7 - 124)和7.2(1.9 - 27.6)。发现8 - 异 - PGF2α是除冠心病已知危险因素(即糖尿病、高胆固醇血症、高血压和吸烟)之外的一个新标志物。所有受试者尿8 - 异 - PGF2α排泄量与危险因素数量相关(趋势P<0.001)。
8 - 异 - PGF2α是冠心病敏感且独立的风险标志物。